Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Xavier

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Circulation. Cardiovascular Quality and Outcomes|November 12, 2019
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES TrialMichael Szarek, Ph Gabriel Steg, Dina DiCenso, et al.
American Heart Journal|September 24, 2017
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)Dragos Vinereanu, Hussein R Al-Khalidi, Meena P Rao, et al.
British Journal of Clinical Pharmacology|March 13, 2026
Prescribing skills course: Three years' experience and lessons learnt through India's massive open online courseShanmugam Lokesh, Sowparnika Treasa Sabu, Manickam Ponnaiah, et al.
Global Heart|April 23, 2016
Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global PopulationsThomas A Gaziano, Shafika Abrahams-Gessel, Sartaj Alam, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Blood|October 17, 2014
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing proceduresDavid Garcia, John H Alexander, Lars Wallentin, et al.
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Stroke|June 8, 2013
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillationMasatsugu Hori, Stuart J Connolly, Jun Zhu, et al.
JAMA Network Open|December 9, 2022
Association of Psychosocial Stress With Risk of Acute StrokeCatriona Reddin, Robert Murphy, Graeme J Hankey, et al.
Cardiovascular Diabetology|August 22, 2022
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetesHertzel C Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Circulation. Cardiovascular Quality and Outcomes|November 12, 2019
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES TrialMichael Szarek, Ph Gabriel Steg, Dina DiCenso, et al.
American Heart Journal|September 24, 2017
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)Dragos Vinereanu, Hussein R Al-Khalidi, Meena P Rao, et al.
British Journal of Clinical Pharmacology|March 13, 2026
Prescribing skills course: Three years' experience and lessons learnt through India's massive open online courseShanmugam Lokesh, Sowparnika Treasa Sabu, Manickam Ponnaiah, et al.
Global Heart|April 23, 2016
Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global PopulationsThomas A Gaziano, Shafika Abrahams-Gessel, Sartaj Alam, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Blood|October 17, 2014
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing proceduresDavid Garcia, John H Alexander, Lars Wallentin, et al.
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Stroke|June 8, 2013
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillationMasatsugu Hori, Stuart J Connolly, Jun Zhu, et al.
JAMA Network Open|December 9, 2022
Association of Psychosocial Stress With Risk of Acute StrokeCatriona Reddin, Robert Murphy, Graeme J Hankey, et al.
Cardiovascular Diabetology|August 22, 2022
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetesHertzel C Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, et al.
Pageof 16